Success Metrics

Clinical Success Rate
83.8%

Based on 62 completed trials

Completion Rate
84%(62/74)
Active Trials
3(3%)
Results Posted
31%(19 trials)
Terminated
12(14%)

Phase Distribution

Ph phase_4
24
27%
Ph not_applicable
10
11%
Ph phase_3
19
22%
Ph phase_1
12
14%
Ph phase_2
19
22%

Phase Distribution

12

Early Stage

19

Mid Stage

43

Late Stage

Phase Distribution84 total trials
Phase 1Safety & dosage
12(14.3%)
Phase 2Efficacy & side effects
19(22.6%)
Phase 3Large-scale testing
19(22.6%)
Phase 4Post-market surveillance
24(28.6%)
N/ANon-phased studies
10(11.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.6%

62 of 76 finished

Non-Completion Rate

18.4%

14 ended early

Currently Active

3

trials recruiting

Total Trials

88

all time

Status Distribution
Active(4)
Completed(62)
Terminated(14)
Other(8)

Detailed Status

Completed62
Terminated12
unknown7
Recruiting2
Withdrawn2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
88
Active
3
Success Rate
83.8%
Most Advanced
Phase 4

Trials by Phase

Phase 112 (14.3%)
Phase 219 (22.6%)
Phase 319 (22.6%)
Phase 424 (28.6%)
N/A10 (11.9%)

Trials by Status

not_yet_recruiting11%
recruiting22%
terminated1214%
unknown78%
withdrawn22%
suspended11%
active_not_recruiting11%
completed6270%

Recent Activity

Clinical Trials (88)

Showing 20 of 88 trialsScroll for more
NCT07352566Phase 4

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Not Yet Recruiting
NCT06083688Phase 4

Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi

Active Not Recruiting
NCT06666491Phase 3

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older

Recruiting
NCT04704999Phase 4

Southeast Asia Dose Optimization of Tafenoquine

Recruiting
NCT00131703Phase 3

Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women

Completed
NCT04349371Phase 2

Saved From COVID-19 - Chloroquine (CQ) Prophylaxis for Health Care Workers at Risk for COVID

Terminated
NCT03529396Phase 2

Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients

Completed
NCT04397679Phase 1

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Terminated
NCT02389374Phase 4

A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh

Completed
NCT01894633Phase 2

Study of Whole-brain Irradiation With Chloroquine for Brain Metastases

Terminated
NCT02432417Phase 2

The Addition of Chloroquine to Chemoradiation for Glioblastoma,

Withdrawn
NCT06044805Phase 4

Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax

Completed
NCT05980156Phase 4

Comparing Chemoprevention Drugs for School-based Malaria Control

Completed
NCT05958797

TES of Chloroquine for Pv in the Philippines in 2016

Completed
NCT04222088

TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014

Completed
NCT05244954Phase 4

Comparing Chemoprevention Approaches for School-based Malaria Control

Completed
NCT03449758Phase 4

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Completed
NCT04368910Phase 3

Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria

Terminated
NCT00455403Not Applicable

Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)

Completed
NCT00440999Phase 3

Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria

Completed

Drug Details

Intervention Type
DRUG
Total Trials
88